MedTrace Logo

Laparoscopic Burch Colposuspension Versus Transobturator Tape in the Treatment of Female Stress Urinary Incontinence.

NCT07398144 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-12

No results posted yet for this study

Summary

The goal of this prospective interventional study is to compare the effectiveness of laparoscopic Burch colposuspension versus trans obturator tape in the treatment of stress urinary incontinence in adult females. The success rate will be compared between the two proceudres at 1, 3 and 6 months post operatively. Operative times, hospital stay and perioperative complications will be evaluated in both arms

Participants will be asked to:

* complete the ICIQ-UI-SF questionnaire pre operatively and at 1, 3 and 6 months post operatively
* undergo a pelvic examination pre operatively
* undergo cough stress test pre operatively and at 1, 3 and 6 months post operatively
* undergo a pressure flow study test pre operatively
* undergo pelviabdominal ultrasound with post void residual urine measurement pre operatively and at 1, 3 and 6 months post operatively
* undergo uroflowmetry at 1 month post operatively

Conditions

  • Female Stress Urinary Incontinence

Interventions

PROCEDURE

laparoscopic Burch colposuspension

laparoscopic Burch colposuspension for female stress urinary incontinence

PROCEDURE

Trans obturator tape fixation

mid urethral sling for female stress urinary incontinence

Sponsors & Collaborators

  • Theodor Bilharz Research Institute

    lead OTHER

Principal Investigators

  • Hussein A Hussein, professor of urology · professor of urology , Faculty of medicine , Cairo university

  • Ahmed I Kamel, professor of urology · professor of urology , Theodor Bilharz Research Institute

  • Ahmed H Abo-Zamel, assistant professor of urology · assistant professor of urology , Faculty of medicine , Cairo university

  • Ahmed S Kamel, lecturer of urology · lecturer of urology , Faculty of medicine , Cairo university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2026-01-02
Completion
2026-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07398144 on ClinicalTrials.gov